📰 Sera Prognostics News
Page 10 - Sera Prognostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sera Prognostics. Real-time updates on events, politics, business and more.
May 23, 2022
Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare Sera Prognostics to similar companies based on the strength of its analyst recommendations, valuation, profitability, risk, earnings, dividends and institutional ownership. Analyst Ratings This is a breakdown […]
May 22, 2022
Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it contrast to its peers? We will compare Sera Prognostics to related companies based on the strength of its valuation, dividends, analyst recommendations, risk, earnings, institutional ownership and profitability. Profitability This table compares Sera Prognostics […]
May 22, 2022
Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 public companies in the “Medical laboratories” industry, but how does it compare to its competitors? We will compare Sera Prognostics to related businesses based on the strength of its earnings, institutional ownership, profitability, dividends, valuation, analyst recommendations and risk. Profitability This table compares Sera Prognostics […]
May 20, 2022
Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its peers? We will compare Sera Prognostics to related businesses based on the strength of its earnings, risk, profitability, institutional ownership, dividends, analyst recommendations and valuation. Insider and Institutional Ownership […]
May 19, 2022
Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it compare to its peers? We will compare Sera Prognostics to related companies based on the strength of its dividends, institutional ownership, analyst recommendations, earnings, profitability, valuation and risk. Analyst Ratings This is a summary […]
May 19, 2022
Results show that the validated proteomics predictor has even greater predictive performance to determine risk of spontaneous preterm birth SALT LAKE CITY, May 19, 2022 /PRNewswire/ -- Sera...
May 18, 2022
Sera Prognostics (NASDAQ:SERA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Sera Prognostics Inc. is a women’s health diagnostics company. It focused on improving maternal and neonatal health by providing […]
May 12, 2022
SERA earnings call for the period ending March 31, 2022.